Arterial vs venous conduits for hepatic artery bypass in pediatric living donor liver transplantation: A retrospective study

Table 1 Baseline and preoperative characteristic comparisons between two groups, n (%)/mean (95%CI)

Characteristics	GSV conduit group (n = 34)	Arterial conduit group (n = 33)	P value
Donors
Sex, female	14 (41.2)	21 (63.6)	0.066
Age (years)	33.7 (8.9)	30.8 (8.2)	0.236
BMI (kg/m2)	21.6 (2.4)	22.1 (2.5)	0.454
≥ CDC III	0	0	NA
Recipients
Sex, male	19 (55.9)	16 (48.5)	0.544
Age (months)	9.0 (4.0-216.0)	12.0 (4.0-216.0)	0.741
Height (cm)	69.0 (56.0-173.0)	71.0 (57.0-173.0)	0.801
Weight (kg)	8.2 (5.0-71.0)	10.0 (5.0-70.0)	0.665
Causes for transplantation			0.614
Biliary atresia	22 (64.7)	19 (57.6)
Liver cancer	7 (20.6)	6 (18.2)
Others	5 (14.7)	8 (24.2)
PELD/MELD score	12.0 (-10.0 to 23.0)	14.0 (-7.0 to 33.0)	0.090
Graft types			0.392
Left lateral segment	19 (55.9)	15 (45.4)
Reduced left lateral segment	4 (11.8)	3 (9.1)
Extended left lateral segment	3 (8.8)	2 (6.1)
Left lobe	3 (8.8)	5 (15.1)
Right lobe without middle hepatic vein	4 (11.8)	2 (6.1)
Right lobe with middle hepatic vein	1 (2.9)	6 (18.2)
History of TACE	6 (17.6)	1 (3.0)	0.105
Graft weight (g)	240.0 (142.0-860.0)	300.0 (180.0-1500.0)	0.104
GRWR (%)	2.41 (0.63-5.31)	2.68 (0.69-5.24)	0.465

BMI: Body mass index; CDC: Clavien-Dindo classification; GRWR: Graft-to-recipient weight ratio; GSV: Great saphenous vein; MELD: Model for end-stage liver disease; PELD: Pediatric end-stage liver disease; TACE: Transcatheter arterial chemoembolization; NA: Not available.